Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 5

Results: 21

How good are our models of cardiovascular disease?
Published in:
2022
By:
- Sobey, Christopher G.;
- Drummond, Grant R.;
- George, Christopher H.
Publication type:
Editorial
Fast voltage‐dependent sodium (NaV) currents are functionally expressed in mouse corpus cavernosum smooth muscle cells.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 1082, doi. 10.1111/bph.15728
By:
- Lim, Xin Rui;
- Bradley, Eamonn;
- Griffin, Caoimhin S.;
- Hollywood, Mark A.;
- Sergeant, Gerard P.;
- Thornbury, Keith D.
Publication type:
Article
Nitric oxide (NO) synthase but not NO, HNO or H2O2 mediates endothelium‐dependent relaxation of resistance arteries from patients with cardiovascular disease.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 1049, doi. 10.1111/bph.15712
By:
- Matthies, Maximilian;
- Rosenstand, Kristoffer;
- Nissen, Inger;
- Muitjens, Stan;
- Riber, Lars P.;
- De Mey, Jo G. R.;
- Bloksgaard, Maria
Publication type:
Article
FGF21 promotes migration and differentiation of epidermal cells during wound healing via SIRT1‐dependent autophagy.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 1102, doi. 10.1111/bph.15701
By:
- Chen, Xixi;
- Tong, Gaozan;
- Fan, Junfu;
- Shen, Yingjie;
- Wang, Nan;
- Gong, Wenjie;
- Hu, Zijing;
- Zhu, Kunxuan;
- Li, Xiaokun;
- Jin, Litai;
- Cong, Weitao;
- Xiao, Jian;
- Zhu, Zhongxin
Publication type:
Article
Established pulmonary hypertension in rats was reversed by a combination of a HIF‐2α antagonist and a p53 agonist.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 1065, doi. 10.1111/bph.15696
By:
- Zheng, Qiuyu;
- Lu, Wenju;
- Yan, Han;
- Duan, Xin;
- Chen, Yuqin;
- Zhang, Chenting;
- Luo, Xiaoyun;
- Chen, Jiyuan;
- Wang, Chao;
- Liu, Shiyun;
- Li, Yi;
- Tang, Haiyang;
- Rahimi, Shamin;
- Rahimi, Shayan;
- Yuan, Jason X.‐J.;
- Zhong, Nanshan;
- Yang, Kai;
- Wang, Jian
Publication type:
Article
The potential anti‐amyloidogenic candidate, SPA1413, for Alzheimer's disease.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 1033, doi. 10.1111/bph.15691
By:
- An, Seong Soo A.;
- Shim, Kyu Hwan;
- Kang, Shinwoo;
- Kim, Young Kyo;
- Subedi, Lalita;
- Cho, Hyewon;
- Hong, Seong‐Min;
- Tan, Mario A.;
- Jeon, Raok;
- Chang, Keun‐A;
- Kim, Sun Yeou
Publication type:
Article
Transgenic rabbit models for cardiac disease research.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 938, doi. 10.1111/bph.15484
By:
- Hornyik, Tibor;
- Rieder, Marina;
- Castiglione, Alessandro;
- Major, Peter;
- Baczko, Istvan;
- Brunner, Michael;
- Koren, Gideon;
- Odening, Katja E.
Publication type:
Article
Mitochondria regulate TRPV4‐mediated release of ATP.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 1017, doi. 10.1111/bph.15687
By:
- Zhang, Xun;
- Lee, Matthew D.;
- Buckley, Charlotte;
- Wilson, Calum;
- McCarron, John G.
Publication type:
Article
Rodent models of hypertension.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 918, doi. 10.1111/bph.15650
By:
- Jama, Hamdi A.;
- Muralitharan, Rikeish R.;
- Xu, Chudan;
- O'Donnell, Joanne A.;
- Bertagnolli, Mariane;
- Broughton, Bradley R. S.;
- Head, Geoffrey A.;
- Marques, Francine Z.
Publication type:
Article
Preclinical models of myocardial infarction: from mechanism to translation.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 770, doi. 10.1111/bph.15595
By:
- Martin, Tamara P.;
- MacDonald, Eilidh A.;
- Elbassioni, Ali Ali Mohamed;
- O'Toole, Dylan;
- Zaeri, Ali Abdullah I.;
- Nicklin, Stuart A.;
- Gray, Gillian A.;
- Loughrey, Christopher M.
Publication type:
Article
Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 748, doi. 10.1111/bph.15591
By:
- Choi, Judy S. Y.;
- de Haan, Judy B.;
- Sharma, Arpeeta
Publication type:
Article
Issue Information.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 743, doi. 10.1111/bph.15548
Publication type:
Article
Control of hippocampal prothrombin kringle‐2 (pKr‐2) expression reduces neurotoxic symptoms in five familial Alzheimer's disease mice.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 998, doi. 10.1111/bph.15681
By:
- Kim, Sehwan;
- Moon, Gyeong Joon;
- Kim, Hyung Jun;
- Kim, Do‐Geun;
- Kim, Jaekwang;
- Nam, Youngpyo;
- Sharma, Chanchal;
- Leem, Eunju;
- Lee, Shinrye;
- Kim, Kyu‐Sung;
- Ha, Chang Man;
- McLean, Catriona;
- Jin, Byung Kwan;
- Shin, Won‐Ho;
- Kim, Dong Woon;
- Oh, Yong‐Seok;
- Hong, Chang‐Won;
- Kim, Sang Ryong
Publication type:
Article
Zebrafish as a tractable model of human cardiovascular disease.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 900, doi. 10.1111/bph.15473
By:
- Bowley, George;
- Kugler, Elizabeth;
- Wilkinson, Rob;
- Lawrie, Allan;
- van Eeden, Freek;
- Chico, Tim J. A.;
- Evans, Paul C.;
- Noël, Emily S.;
- Serbanovic‐Canic, Jovana
Publication type:
Article
Preclinical rodent models of cardiac fibrosis.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 882, doi. 10.1111/bph.15450
By:
- Wang, Yan;
- Wang, Miao;
- Samuel, Chrishan S.;
- Widdop, Robert E.
Publication type:
Article
Animal models of pulmonary hypertension: Getting to the heart of the problem.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 811, doi. 10.1111/bph.15444
By:
- Dignam, Joshua P.;
- Scott, Tara E.;
- Kemp‐Harper, Barbara K.;
- Hobbs, Adrian J.
Publication type:
Article
The canine chronic atrioventricular block model in cardiovascular preclinical drug research.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 859, doi. 10.1111/bph.15436
By:
- Loen, Vera;
- Vos, Marc A.;
- van der Heyden, Marcel A. G.
Publication type:
Article
Anti‐arrhythmic investigations in large animal models of atrial fibrillation.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 838, doi. 10.1111/bph.15417
By:
- Saljic, Arnela;
- Jespersen, Thomas;
- Buhl, Rikke
Publication type:
Article
Ilexgenin A restrains CRTC2 in the cytoplasm to prevent SREBP1 maturation via AMP kinase activation in the liver.
Published in:
2022
By:
- Lu, Yawen;
- Ma, Jingjie;
- Li, Ping;
- Liu, Baolin;
- Wen, Xiaodong;
- Yang, Jie
Publication type:
journal article
The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture.
Published in:
2022
By:
- Noonan, Jonathan;
- Bobik, Alex;
- Peter, Karlheinz
Publication type:
journal article
Mouse models for abdominal aortic aneurysm.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 5, p. 792, doi. 10.1111/bph.15260
By:
- Golledge, Jonathan;
- Krishna, Smriti Murali;
- Wang, Yutang
Publication type:
Article

Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 5

How good are our models of cardiovascular disease?

Fast voltage‐dependent sodium (Na<sub>V</sub>) currents are functionally expressed in mouse corpus cavernosum smooth muscle cells.

Nitric oxide (NO) synthase but not NO, HNO or H<sub>2</sub>O<sub>2</sub> mediates endothelium‐dependent relaxation of resistance arteries from patients with cardiovascular disease.

FGF21 promotes migration and differentiation of epidermal cells during wound healing via SIRT1‐dependent autophagy.

Established pulmonary hypertension in rats was reversed by a combination of a HIF‐2α antagonist and a p53 agonist.

The potential anti‐amyloidogenic candidate, SPA1413, for Alzheimer's disease.

Transgenic rabbit models for cardiac disease research.

Mitochondria regulate TRPV4‐mediated release of ATP.

Rodent models of hypertension.

Preclinical models of myocardial infarction: from mechanism to translation.

Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis.

Issue Information.

Control of hippocampal prothrombin kringle‐2 (pKr‐2) expression reduces neurotoxic symptoms in five familial Alzheimer's disease mice.

Zebrafish as a tractable model of human cardiovascular disease.

Preclinical rodent models of cardiac fibrosis.

Animal models of pulmonary hypertension: Getting to the heart of the problem.

The canine chronic atrioventricular block model in cardiovascular preclinical drug research.

Anti‐arrhythmic investigations in large animal models of atrial fibrillation.

Ilexgenin A restrains CRTC2 in the cytoplasm to prevent SREBP1 maturation via AMP kinase activation in the liver.

The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture.

Mouse models for abdominal aortic aneurysm.